1. VOA英语学习网
  2. 设首页|英语四级|英语六级|英语日记|英文自我介绍|英语话剧剧本
  3. 打包下载 | VOA打包 | BBC打包 | 日语 韩语
  4. 手机版
  1. 英语学习网站推荐
  2. 剑桥英语考试认证
  3. 外教口语面对面课程


Advisors to the Food and Drug Administration are meeting Thursday to consider giving the go ahead to gene therapy aimed at improving vision for some people with hereditary blindness. It would be the first gene therapy in the U.S. for an inherited disease and the first in which a corrective gene is given directly to a patient. The eye treatment Luxturna is intended to be given just once and supplies a gene to make a protein needed for sight which is missing in people with a defective gene. A study of 29 patients found it improved vision for nearly all who received it and it seemed safe. Luxturna is made by Philadelphia based Spark Therapeutics. Lilian Woo, FOX News. 来自:VOA英语网 文章地址: http://www.tingvoa.com/html/20171226/522864.html